US suspends 'war on Islam' military course

May 12, 2012

us_suspended

Washington, May 12: A course for US military officers has been teaching that America's enemy is Islam in general, not just terrorists, and suggesting that the country might ultimately have to obliterate the Islamic holy cities of Mecca and Medina without regard for civilian deaths, following World War II precedents of the nuclear attack on Hiroshima or the allied firebombing of Dresden.

The Pentagon suspended the course in late April when a student objected to the material . The FBI also changed some agent training last year after discovering that it, too, was critical of Islam. The teaching in military course was counter to repeated assertions by US officials over the past decade that America is at war against Islamic extremists , not the religion itself.

"They hate everything you stand for and will never coexist with you, unless you submit ," the instructor, army Lt Col Matthew Dooley, said in a presentation last July for the course at Joint Forces Staff College in Norfolk, Virginia.

The college, for professional military members, teaches midlevel officers and government civilians on subjects related to planning and executing war. Dooley also presumed, for the purposes of his theoretical war plan, that the Geneva Conventions that set standards of armed conflict are "no longer relevant" . He adds: "This would leave open the option once again of taking war to a civilian population wherever necessary (precedents of Dresden, Tokyo , Hiroshima, Nagasaki being applicable... )".

His war plan suggests possible outcomes such as "Saudi Arabia threatened with starvation ... Islam reduced to cult status" and the Muslim holy cities of Mecca and Medina in Saudi Arabia "destroyed" .

A copy of the presentation was obtained and posted online by Wired.com's Danger Room blog. The college did not respond to The Associated Press' requests for copies of the documents, but a Pentagon spokesman authenticated the documents. Dooley still works for the college, but is no longer teaching, Joint Chiefs Chairman Gen Martin Dempsey said. Dooley refused to comment, saying "Can't talk to you, sir," and hanging up when reached by telephone at his office on Thursday. A summary of Dooley's military service record provided by Army Human Resources Command at Fort Knox, Kentucky, shows that he was commissioned as a second lieutenant upon graduation from the US Military Academy in May 1994. He has served overseas tours in Germany, Bosnia, Kuwait and Iraq. He has numerous awards including a Bronze Star Medal, the fourth-highest military award for bravery, or meritorious service.

In what he termed a model for a campaign to force a transformation of Islam, Dooley called for "a direct ideological and philosophical confrontation with Islam" , with the presumption that Islam is an ideology. He asserted that Islam has already declared war on the West, and the US specifically. "It is therefore illogical" to continue with the current US strategy, which Dooley said presumes there is a way of finding common ground with Islamic religious leaders without "waging near 'total war,'" he wrote.


Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 21,2020

Rome, Mar 21: Italy on Friday reported a record 627 new deaths from the novel coronavirus, taking its overall toll past 4,000 as the pandemic gathered pace despite government efforts to halt its spread.

The total number of deaths was 4,032, with the number of infections reaching 47,021.

Italy's previous one-day record death toll was 475 on Wednesday.

The nation of 60 million now accounts for 36.6 percent of the world's coronavirus deaths.

Italy has seen more than 1,500 deaths from COVID-19 in the past three days alone.

Its current daily death rate is higher than that officially reported by China at the peak of its outbreak around Wuhan's Hubei province.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 20,2020

Paris, Jul 20: Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said on Monday.

The first trial among more than 1,000 adults in Britain found that the vaccine induced "strong antibody and T cell immune responses" against the novel coronavirus.

A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response.

The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use.

The authors of the studies said that they encountered few adverse side-effects from the vaccine candidates.

However, they cautioned that more research was needed, particularly among older adults, who are disproportionately at risk of dying of COVID-19.

Co-author Sarah Gilbert from the University of Oxford said the results "hold promise".

"If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.